Advertisement
Screener

Oncolix, Inc. Financing Cash Flow

Oncolix, Inc. Financing Cash Flow

Oncolix, Inc. reported Financing Cash Flow of $948.53 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-19.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2018-11-19

  • Oncolix, Inc. net cash provided by (used in) financing activities for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
  • Oncolix, Inc. net cash provided by (used in) financing activities for the quarter ending 2017-12-31 was -$38.69K, a 185.27% decline year-over-year.
  • Oncolix, Inc. net cash provided by (used in) financing activities for the quarter ending 2017-09-30 was $1.87M, a 1262.98% increase year-over-year.
  • Oncolix, Inc. net cash provided by (used in) financing activities for the quarter ending 2017-06-30 was $4.32K.
  • Oncolix, Inc. net cash provided by (used in) financing activities for fiscal 2017 was $2.86M, a 1434.07% increase from fiscal 2016.
  • Oncolix, Inc. net cash provided by (used in) financing activities for fiscal 2016 was $186.47K.
  • Oncolix, Inc. net cash provided by (used in) financing activities for fiscal 2014 was $81.80K, a 136.42% increase from fiscal 2013.
  • Oncolix, Inc. net cash provided by (used in) financing activities for fiscal 2013 was $34.60K.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 9 month as first filedNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 12 month as first filed
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19
$948.53K
10-Q · filed 2018-11-19
2018-06-30$948.53K
10-Q · filed 2018-08-09
2017-12-31-$38.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$1.83M
derived: sum of 2 quarters · filed 2018-11-19
$1.83M
derived: sum of 3 quarters · filed 2018-11-19
$2.86M
10-K · filed 2018-03-14
2017-09-30$1.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19
$1.87M
derived: sum of 2 quarters · filed 2018-11-19
$2.90M
10-Q · filed 2018-11-19
$2.94M
derived: sum of 4 quarters · filed 2018-11-19
2017-06-30$4.32K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$1.03M
10-Q · filed 2018-08-09
$1.08M
derived: sum of 3 quarters · filed 2018-08-09
$1.21M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$1.03M
10-Q · filed 2018-05-14
$1.07M
derived: sum of 2 quarters · filed 2018-05-14
$1.21M
derived: sum of 3 quarters · filed 2018-05-14
2016-12-31$45.37K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-14
$182.47K
derived: sum of 2 quarters · filed 2018-03-14
$186.47K
10-K · filed 2018-03-14
$4.77M
10-K · filed 2017-04-05
2016-09-30$137.10K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-11-24
$141.10K
10-Q/A · filed 2017-11-24
$16.33K
10-Q · filed 2016-11-22
2016-06-30$4.00K
10-Q/A · filed 2017-10-05
2014-12-31$9.80K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14
$64.30K
derived: sum of 2 quarters · filed 2016-04-14
$76.80K
derived: sum of 3 quarters · filed 2016-04-14
$81.80K
10-K · filed 2016-04-14
2014-09-30$54.50K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-08
$67.00K
derived: sum of 2 quarters · filed 2015-12-08
$72.00K
10-Q · filed 2015-12-08
2014-06-30$12.50K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19
$17.50K
10-Q · filed 2015-08-19
2014-03-31$5.00K
10-Q · filed 2015-05-20
2013-12-31$34.60K
10-K · filed 2015-03-26